Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts that cover Ironwood Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $4.94, which forecasts a 46.59% increase in the stock price over the next year. The lowest target is $0.70 and the highest is $10.

Price Target: $4.94 (+46.59%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$0.70	$4.94	$5.00	$10
Change	-79.23%	+46.59%	+48.37%	+196.74%

Analyst Ratings

The average analyst rating for Ironwood Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	1	0	0
Buy	1	1	1	2	2	2
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason N. Butler Citizens	Citizens	Buy Maintains $8 → $10	Buy	Maintains	$8 → $10	+196.74%	Feb 26, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Hold Maintains $3 → $5	Hold	Maintains	$3 → $5	+48.37%	Jan 5, 2026
Jason Butler Citizens	Citizens	Hold → Buy Upgrades $8	Hold → Buy	Upgrades	$8	+137.39%	Jan 5, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Hold Maintains $1 → $3	Hold	Maintains	$1 → $3	-10.98%	Nov 11, 2025
Mohit Bansal Wells Fargo	Wells Fargo	Buy → Hold Downgrades $7 → $1	Buy → Hold	Downgrades	$7 → $1	-70.33%	Apr 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

467.77M

Increased by 57.95%

from 296.15M

Revenue Next Year

488.30M

Increased by 4.39%

from 467.77M

EPS This Year

1.18

Increased by 693.88%

from 0.15

EPS Next Year

1.34

Increased by 13.85%

from 1.18

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	413.75M	410.60M	442.74M	351.41M	296.15M	467.77M	488.30M
Revenue Growth	6.22%	-0.76%	7.83%	-20.63%	-15.73%	57.95%	4.39%
EPS	3.21	0.96	-6.45	0.01	0.15	1.18	1.34
EPS Growth	386.36%	-69.98%	-	-	2,583.01%	693.88%	13.85%
Forward PE	-	-	-	-	-	2.86	2.51
No. Analysts	-	-	-	-	-	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	486.9M	516.1M
Avg	467.8M	488.3M
Low	442.9M	457.7M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	64.4%	10.3%
Avg	57.9%	4.4%
Low	49.6%	-2.2%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	1.22	1.40
Avg	1.18	1.34
Low	1.13	1.27

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	720.8%	18.5%
Avg	693.9%	13.9%
Low	659.4%	8.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.